Dr. Kathleen A. Killoran, MD

Dr. Killoran practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Killoran's NPI, 1558551242, was assigned on July 28, 2007. Dr. Killoran graduated from St. George's University School of Medicine in 2004. Dr. Killoran holds New York license 265238-1.

Dr. Killoran's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Killoran's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dr. Killoran is also affiliated with Glens Falls Hospital. The medical group on file is MSK Ralph Lauren Center. Dmand AI also links Dr. Killoran to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Killoran practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Killoran's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Killoran is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Killoran's licenses on file in 4 states: New York, District of Columbia, Maryland and Georgia.

Dmand AI lists breast cancer, multiple myeloma and neutropenia among the conditions Dr. Killoran treats.

CMS data shows 109 Medicare services from Dr. Killoran across 2 procedure codes in 2024, all of them office visits, for 35 Medicare patients. Medicare paid $8,086 for them. Every service was in an office.

CMS counts 35 Medicare patients who saw Dr. Killoran in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have cancer, and 75% have high blood pressure. 40% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Killoran's median patient age at 69, with 89% women.

In 2024, Dr. Killoran wrote 508 Medicare Part D claims for 76 patients. 75% of them were for generic drugs. CMS names the drug for 375 of them, across 13 drugs with 11 or more claims each, at $1,444,634 in total drug cost. In 2023, CMS named 218 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Killoran for performance year 2024, reported as part of a group. Dr. Killoran accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Killoran as offering telehealth.

CMS Open Payments shows 3 general payments to Dr. Killoran from 3 drug and device companies from 2017 to 2021. Food and beverage make up the largest share, 92% of the total. Sirtex Medical Inc paid the most, $108.

Dr. Killoran graduated from St. George's University School of Medicine in 2004. Dr. Killoran is a member of ASCO.

Dr. Killoran is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.